These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23752649)

  • 21. Extracts of Equisetum giganteum L and Copaifera reticulate Ducke show strong antiviral activity against the sexually transmitted pathogen herpes simplex virus type 2.
    Churqui MP; Lind L; Thörn K; Svensson A; Savolainen O; Aranda KT; Eriksson K
    J Ethnopharmacol; 2018 Jan; 210():192-197. PubMed ID: 28807852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic analogues of bovine bactenecin dodecapeptide reduce herpes simplex virus type 2 infectivity in mice.
    Shestakov A; Jenssen H; Hancock RE; Nordström I; Eriksson K
    Antiviral Res; 2013 Nov; 100(2):455-9. PubMed ID: 24012999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contortrostatin, a homodimeric disintegrin isolated from snake venom inhibits herpes simplex virus entry and cell fusion.
    Hubbard S; Choudhary S; Maus E; Shukla D; Swenson S; Markland FS; Tiwari V
    Antivir Ther; 2012; 17(7):1319-26. PubMed ID: 22875654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo evaluation of a novel antiherpetic flavonoid, 4'-phenylflavone, and its synergistic actions with acyclovir.
    Hayashi K; Iinuma M; Sasaki K; Hayashi T
    Arch Virol; 2012 Aug; 157(8):1489-98. PubMed ID: 22580497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel selective LSD1/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency.
    Liang Y; Quenelle D; Vogel JL; Mascaro C; Ortega A; Kristie TM
    mBio; 2013 Feb; 4(1):e00558-12. PubMed ID: 23386436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of HSV Glycoproteins in Mediating Cell Entry.
    Arii J; Kawaguchi Y
    Adv Exp Med Biol; 2018; 1045():3-21. PubMed ID: 29896660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic Studies of Viral Entry: An Overview of Dendrimer-Based Microbicides As Entry Inhibitors Against Both HIV and HSV-2 Overlapped Infections.
    Sepúlveda-Crespo D; Ceña-Díez R; Jiménez JL; Ángeles Muñoz-Fernández M
    Med Res Rev; 2017 Jan; 37(1):149-179. PubMed ID: 27518199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virostatic potential of micro-nano filopodia-like ZnO structures against herpes simplex virus-1.
    Mishra YK; Adelung R; Röhl C; Shukla D; Spors F; Tiwari V
    Antiviral Res; 2011 Nov; 92(2):305-12. PubMed ID: 21893101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resveratrol as a Novel Anti-Herpes Simplex Virus Nutraceutical Agent: An Overview.
    Annunziata G; Maisto M; Schisano C; Ciampaglia R; Narciso V; Tenore GC; Novellino E
    Viruses; 2018 Sep; 10(9):. PubMed ID: 30177661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new promising candidate to overcome drug resistant herpes simplex virus infections.
    Zinser E; Krawczyk A; Mühl-Zürbes P; Aufderhorst U; Draßner C; Stich L; Zaja M; Strobl S; Steinkasserer A; Heilingloh CS
    Antiviral Res; 2018 Jan; 149():202-210. PubMed ID: 29155164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Herpes simplex virus infection.
    Whitley RJ
    Semin Pediatr Infect Dis; 2002 Jan; 13(1):6-11. PubMed ID: 12118847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A sugar binding protein cyanovirin-N blocks herpes simplex virus type-1 entry and cell fusion.
    Tiwari V; Shukla SY; Shukla D
    Antiviral Res; 2009 Oct; 84(1):67-75. PubMed ID: 19665490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-(1-Substituted) alkyl pyrimidine nucleosides as antiviral (herpes) agents.
    Kumar R
    Curr Med Chem; 2004 Oct; 11(20):2749-66. PubMed ID: 15544474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection.
    Antoine TE; Mishra YK; Trigilio J; Tiwari V; Adelung R; Shukla D
    Antiviral Res; 2012 Dec; 96(3):363-75. PubMed ID: 23047013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro anti-HIV and -HSV activity and safety of sodium rutin sulfate as a microbicide candidate.
    Tao J; Hu Q; Yang J; Li R; Li X; Lu C; Chen C; Wang L; Shattock R; Ben K
    Antiviral Res; 2007 Sep; 75(3):227-33. PubMed ID: 17459492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of herpes simplex virus types 1 and 2 replication in vitro by mercurithio analogs of deoxyuridine.
    Holliday J; Williams MV
    Antiviral Res; 1991 Sep; 16(2):197-203. PubMed ID: 1665962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Herpes Simplex Virus 1 Can Enter Dynamin 1 and 2 Double-Knockout Fibroblasts.
    Möckel M; Rahn E; de la Cruz N; Wirtz L; van Lent JWM; Pijlman GP; Knebel-Mörsdorf D
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31142668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses.
    Piret J; Lamontagne J; Bestman-Smith J; Roy S; Gourde P; Désormeaux A; Omar RF; Juhász J; Bergeron MG
    J Clin Microbiol; 2000 Jan; 38(1):110-9. PubMed ID: 10618073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-Infectivity against Herpes Simplex Virus and Selected Microbes and Anti-Inflammatory Activities of Compounds Isolated from
    Brezáni V; Leláková V; Hassan STS; Berchová-Bímová K; Nový P; Klouček P; Maršík P; Dall'Acqua S; Hošek J; Šmejkal K
    Viruses; 2018 Jul; 10(7):. PubMed ID: 29986399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of myosin light chain kinase can be targeted for the development of new therapies against herpes simplex virus type-1 infection.
    Antoine TE; Shukla D
    Antivir Ther; 2014; 19(1):15-29. PubMed ID: 23813409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.